临床试验支援服务市场规模、份额及成长分析（按服务、阶段、研究设计、适应症、发起方和地区）－2025 年至 2032 年产业预测

临床试验支援服务市场规模预计在 2023 年达到 230 亿美元，从 2024 年的 248.4 亿美元成长到 2032 年的 459.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.0%。

临床试验产业经历了重大变革，尤其是自疫情爆发以来，重点关注临床试验、检测设计和支援服务。保护和储存研究药物、确保临床实验地点的安全、计算药物剂量和管理套件等基本业务在这一领域发挥关键作用。许多被推迟的临床试验的恢復，特别是在2021年新冠疫苗研发之后，也凸显了新兴市场迫切需要创新药物来应对日益增多的慢性病、感染疾病和热带病。此外，向虚拟临床试验的转变已成为临床试验支援服务收益成长的主要驱动力，研究公司越来越多地采用虚拟技术来提高其临床研究方法的效率。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

临床试验支援服务市场规模（按服务类型和复合年增长率）（2025-2032）

• 市场概览
• 管理人员
• 临床试验现场管理
  • 病患招募及登记服务
  • 病患招募管理
  • 患者保留
• 资料管理
• 机构审查委员会

临床试验支援服务市场规模（分阶段）及复合年增长率（2025-2032）

• 市场概览
• 第一阶段
• 第二阶段
• 第三阶段
• 第四阶段

临床试验支援服务市场规模（依研究设计和复合年增长率） (2025-2032)

• 市场概览
• 扩展访问
• 介入
• 观察性

临床试验支援服务市场规模（按适应症和复合年增长率）（2025-2032）

• 市场概览
• 自体免疫或炎症
• 心血管
• 糖尿病
• 肿瘤学

临床试验支援服务市场规模（按赞助商和复合年增长率） (2025-2032)

• 市场概览
• 医疗设备
• 製药和生物製药

临床试验支援服务市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Laboratory Corporation of America Holdings（LabCorp）（USA）
• Charles River Laboratories International, Inc.（USA）
• Syneos Health, Inc.（USA）
• Parexel International Corporation（USA）
• ICON plc（Ireland）
• Wuxi AppTec Co., Ltd.（China）
• Eurofins Scientific（Luxembourg）
• ACM Global Laboratories（USA）
• Clinipace Worldwide（USA）
• Worldwide Clinical Trials（USA）
• Premier Research（USA）
• PSI CRO AG（Switzerland）
• Novotech（Australia）
• Velocity Clinical Research（USA）
• Fortrea（USA）
• CTI Clinical Trial and Consulting Services（USA）

结论和建议

Clinical Trials Support Services Market size was valued at USD 23.0 billion in 2023 and is poised to grow from USD 24.84 billion in 2024 to USD 45.98 billion by 2032, growing at a CAGR of 8.0% during the forecast period (2025-2032).

The clinical trials industry has witnessed significant evolution, particularly post-pandemic, with an emphasis on clinical testing, assay design, and support services. Essential operations such as securing and storing research medications, safeguarding trial sites, calculating drug dosages, and managing kits play a vital role in this domain. The resurgence of numerous postponed trials, particularly after the development of COVID-19 vaccines in 2021, has also highlighted the urgent need for innovative pharmaceuticals to address rising chronic, infectious, and tropical diseases in emerging markets. Additionally, the shift towards virtual clinical trials has emerged as a key driver of revenue growth in clinical trial support services, as research firms increasingly adopt virtual technologies to enhance the efficiency of their clinical research processes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Trials Support Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Trials Support Services Market Segments Analysis

Global Clinical Trials Support Services Market is segmented by Service, Phase, Study Design, Indication, Sponsor and region. Based on Service, the market is segmented into Administrative Staff, Clinical Trial Site Management, Data Management and Institutional Review Boards. Based on Phase, the market is segmented into Phase I, Phase II, Phase III and Phase IV. Based on Study Design, the market is segmented into Expanded Access, Interventional and Observational. Based on Indication, the market is segmented into Autoimmune or Inflammation, Cardiovascular, Diabetes and Oncology. Based on Sponsor, the market is segmented into Medical Devices and Pharmaceutical & Biopharmaceutical. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Clinical Trials Support Services Market

The growth of the Clinical Trials Support Services market is primarily driven by several key factors, including the increasing prevalence of infectious and chronic diseases, which necessitates extensive research efforts. Additionally, pharmaceutical companies are investing significantly in research and development, further fueling market expansion. The rise of contract research organizations (CROs) is also contributing to this trend, as they offer specialized expertise and resources for conducting clinical trials. Furthermore, the escalating demand for clinical trials in emerging markets is creating new opportunities, ultimately driving the overall growth and evolution of the Clinical Trials Support Services landscape.

Restraints in the Clinical Trials Support Services Market

The growth of the Clinical Trials Support Services market is hindered by insufficient medical infrastructure and advanced technological equipment. Moreover, strict regulations surrounding patient recruitment and the absence of robust management frameworks for the trials pose significant challenges to the market's overall development. However, there remains a promising opportunity for growth driven by the globalization of clinical trials and continuous advancements in technology resulting from ongoing research and development efforts. Addressing these constraints could pave the way for a more dynamic market environment, fostering innovation and improving the efficiency of clinical trial processes.

Market Trends of the Clinical Trials Support Services Market

The Clinical Trials Support Services market is poised for significant growth due to several key trends. The increasing demand for clinical trials in emerging nations, propelled by improved regulatory frameworks and healthcare infrastructure, is driving expansion. Additionally, rising research and development (R&D) investments from pharmaceutical companies, largely fueled by patent expirations, are escalating the need for efficient trial execution. The proliferation of contract research organizations (CROs) further enhances this trend, as they offer specialized services that streamline the trial process and reduce costs. Collectively, these factors indicate a robust and rapidly expanding global market for clinical trials support services.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Clinical Trials Support Services Market Size by Service & CAGR (2025-2032)

• Market Overview
• Administrative Staff
• Clinical Trial Site Management
  • Patient Recruitment & Registry Services
  • Patient Recruitment Management
  • Patient Retention
• Data Management
• Institutional Review Boards

Global Clinical Trials Support Services Market Size by Phase & CAGR (2025-2032)

• Market Overview
• Phase I
• Phase II
• Phase III
• Phase IV

Global Clinical Trials Support Services Market Size by Study Design & CAGR (2025-2032)

• Market Overview
• Expanded Access
• Interventional
• Observational

Global Clinical Trials Support Services Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Autoimmune or Inflammation
• Cardiovascular
• Diabetes
• Oncology

Global Clinical Trials Support Services Market Size by Sponsor & CAGR (2025-2032)

• Market Overview
• Medical Devices
• Pharmaceutical & Biopharmaceutical

Global Clinical Trials Support Services Market Size & CAGR (2025-2032)

• North America (Service, Phase, Study Design, Indication, Sponsor)
  • US
  • Canada
• Europe (Service, Phase, Study Design, Indication, Sponsor)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service, Phase, Study Design, Indication, Sponsor)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service, Phase, Study Design, Indication, Sponsor)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service, Phase, Study Design, Indication, Sponsor)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Laboratory Corporation of America Holdings (LabCorp) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuxi AppTec Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACM Global Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinipace Worldwide (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Worldwide Clinical Trials (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Premier Research (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PSI CRO AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novotech (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Velocity Clinical Research (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fortrea (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CTI Clinical Trial and Consulting Services (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations